You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API DIAZOXIDE

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing DIAZOXIDE

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Teva Pharmaceuticals USA Inc	PROGLYCEM	diazoxide	0575-6200	ALCOHOL
Teva Pharmaceuticals USA Inc	PROGLYCEM	diazoxide	0575-6200	CARBOXYMETHYLCELLULOSE SODIUM
Teva Pharmaceuticals USA Inc	PROGLYCEM	diazoxide	0575-6200	HYDROCHLORIC ACID
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing DIAZOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Par Pharmaceutical Inc	diazoxide	0254-1010	ALCOHOL
Par Pharmaceutical Inc	diazoxide	0254-1010	CARBOXYMETHYLCELLULOSE SODIUM
Par Pharmaceutical Inc	diazoxide	0254-1010	FD&C RED NO. 40
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for DIAZOXIDE

Excipient focus: ALCOHOL

DIAZOXIDE drug variants containing ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

DIAZOXIDE drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C RED NO. 40

DIAZOXIDE drug variants containing FD&C RED NO. 40

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing FD&C RED NO. 40

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

Excipient focus: FD&C YELLOW NO. 6

DIAZOXIDE drug variants containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

Excipient focus: HYDROCHLORIC ACID

DIAZOXIDE drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM ALUMINUM SILICATE

DIAZOXIDE drug variants containing MAGNESIUM ALUMINUM SILICATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing MAGNESIUM ALUMINUM SILICATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN

DIAZOXIDE drug variants containing METHYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing METHYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLOXAMER 188

DIAZOXIDE drug variants containing POLOXAMER 188

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing POLOXAMER 188

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

DIAZOXIDE drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE OXIDE

DIAZOXIDE drug variants containing PROPYLENE OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing PROPYLENE OXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

Excipient focus: PROPYLPARABEN

DIAZOXIDE drug variants containing PROPYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing PROPYLPARABEN

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM BENZOATE

DIAZOXIDE drug variants containing SODIUM BENZOATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing SODIUM BENZOATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

DIAZOXIDE drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

Excipient focus: SORBITOL

DIAZOXIDE drug variants containing SORBITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing SORBITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

Excipient focus: SORBITOL SOLUTION 70%

DIAZOXIDE drug variants containing SORBITOL SOLUTION 70%

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing SORBITOL SOLUTION 70%

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

Excipient focus: WATER

DIAZOXIDE drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Par Pharmaceutical Inc	diazoxide	0254-1010
Teva Pharmaceuticals USA Inc	diazoxide	0575-6200
e5 Pharma LLC	diazoxide	13517-100
>Company	>Ingredient	>NDC

DIAZOXIDE drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
TriRx Huntsville Pharmaceutical Services LLC	diazoxide oral suspension	80432-057
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.